Bree Foster, PhD
Bree Foster is a science writer at Drug Discovery News with over 2 years of experience at Technology Networks, Drug Discovery News, and other scientific marketing agencies. She holds a PhD in comparative and functional genomics from the University of Liverpool and enjoys crafting compelling stories for science.
Articles by Bree Foster, PhD
| 3 min read
The new therapy combines a chemically enhanced drug with tumor-targeted delivery to overcome resistance and reduce side effects.
| 3 min read
The therapy exploits the properties of a neutrophil-derived enzyme to selectively kill tumor cells while preserving healthy immune cells.
| 4 min read
Radiprodil is in development as the first therapy designed to directly address the underlying biology of GRIN-related neurodevelopmental disorder.
| 6 min read
With the first wave of FDA-approved siRNA drugs under their belt, companies are racing to expand into new tissues and indications.
| 3 min read
Researchers are using caraway seeds to create synthetic cannabidiol compounds for treating seizures.
| 5 min read
Explore the mechanisms, clinical applications, and future opportunities of GLP-1 receptor agonists in drug development and disease management.
| 3 min read
How a team at Pfizer turned a decade-old compound into the fastest small molecule drug for COVID-19.
| 4 min read
Researchers are turning bacterial transport systems from obstacles into opportunities for targeted therapy.
| 4 min read
Scientists are using insights from viral hijacking to chemically reprogram E3 ligases, opening new opportunities in drug discovery.
| 5 min read
After a decade of promise, AAV therapies are now confronting economic, clinical, and regulatory hurdles.
| 6 min read
Advances in biofabrication and regulatory momentum are accelerating the move from 2D cultures and animal models to scalable, human-relevant systems.
| 3 min read
A team from Stanford and NYU shows how Bacteroides fragilis can activate pain pathways, revealing a new microbial culprit in digestive disease.
